Debt تغيير تاريخ
AbbVie USD 60.75B 269M 2023-09
Abbott USD 16.85B 54M 2023-06
Amgen USD 64.61B 4.15B 2023-12
AstraZeneca USD 28.58B 1.26B 2023-09
Baxter International USD 13.8B 2.7B 2023-12
Bayer EUR 47.42B 907M 2023-09
Becton, Dickinson and Co. USD 16.11B 231M 2023-12
Biogen USD 6.94B 348.2M 2023-12
Boston Scientific USD 8.9B 154M 2023-09
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
CONMED USD 1.01B 28.32M 2023-09
Cooper Companies USD 2.77B 203.1M 2023-12
Dexcom USD 2.49B 121.7M 2023-12
Edwards Lifesciences USD 597M 200K 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Globus Medical USD 418.21M 7.2M 2023-12
Hologic USD 2.58B 258.6M 2023-12
Insulet USD 1.42B 4.6M 2023-12
Integra LifeSciences USD 1.5B 5.45M 2023-12
Intuitive Surgical USD 0 0 2022-03
J&J USD 29.92B 15.68B 2023-09
Merck USD 34.86B 2.05B 2023-09
Merit Medical Systems USD 823.01M 536.89M 2023-12
Novartis USD 210M 28.09B 2023-09
Pfizer USD 63.6B 1.74B 2023-09
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Stryker USD 10.9B 1.79B 2023-12
Tandem Diabetes Care USD 285.03M 455K 2023-12
Teva Pharmaceutical Industries USD 19.97B 704M 2023-09
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09
Zimmer Biomet Holdings USD 5.77B 285.5M 2023-12
Zoetis USD 6.57B 13M 2023-12



J&J الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.